Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome
Elisabeth M. van Zutphen, Didi Rhebergen, Eric van Exel, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review
Mario Ignacio Zelada, Verónica Garrido, Andrés Liberona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14810-14810
Open Access | Times Cited: 29
The role of neurotrophic factors in novel, rapid psychiatric treatments
Jihye Kim, Michelle He, Alina K. Widmann, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 227-245
Closed Access | Times Cited: 25
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood
Clara Aabye Madsen, Miriam L. Navarro, Betina Elfving, et al.
European Neuropsychopharmacology (2024) Vol. 87, pp. 35-55
Closed Access | Times Cited: 6
Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications
Milagros Rojas, Daniela Ariza, Ángel Ortega, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6918-6918
Open Access | Times Cited: 27
Methylome-wide change associated with response to electroconvulsive therapy in depressed patients
Lea Sirignano, Josef Frank, Laura Kranaster, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy
Piyush Pathak, Aseem Mehra, Sant Ram, et al.
Behavioural Brain Research (2022) Vol. 430, pp. 113931-113931
Closed Access | Times Cited: 13
The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy
Alexandra S. Troyan, Oleg A. Levada
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 20
Longitudinal alterations in mRNA expression of the BDNF neurotrophin signaling cascade in blood correlate with changes in depression scores in patients undergoing electroconvulsive therapy
Geert Schurgers, Sharon Walter, Ehsan Pishva, et al.
European Neuropsychopharmacology (2022) Vol. 63, pp. 60-70
Closed Access | Times Cited: 11
Diabetes mellitus type 2 impedes functional recovery, neuroplasticity and quality of life after stroke
Poonam Chaturvedi, Ajai Kumar Singh, Vandana Tiwari, et al.
Journal of Family Medicine and Primary Care (2020) Vol. 9, Iss. 2, pp. 1035-1035
Open Access | Times Cited: 15
<p>BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study</p>
Xingbing Huang, Xiong Huang, Hongbo He, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 901-908
Open Access | Times Cited: 15
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
Wei Zheng, Li-Mei Gu, Yanling Zhou, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 4, pp. 1013-1021
Open Access | Times Cited: 9
Biomolecular Research on Electroconvulsive Therapy for Mental Disorders: State of the Art and Future Directions
Daniele Cavaleri, Francesco Bartoli
ALPHA PSYCHIATRY (2022) Vol. 23, Iss. 2, pp. 57-58
Open Access | Times Cited: 8
Electroconvulsive Therapy for Treatment-Resistant Depression: Dispelling the Stigma
Deborah Salani, Deana Goldin, Beatriz Valdes, et al.
Journal of Psychosocial Nursing and Mental Health Services (2023) Vol. 61, Iss. 6, pp. 11-17
Closed Access | Times Cited: 4
Electroconvulsive therapy in the Fourth Industrial Revolution (Review)
Zvezdana Stojanović, Katarina Simić, Vesna Tepšić Ostojić, et al.
Biomedical Reports (2024) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study
Wei Zheng, Qiao-Mei Cen, Sha Nie, et al.
PeerJ (2021) Vol. 9, pp. e10699-e10699
Open Access | Times Cited: 10
Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression
Sonani Mindt, Michael Neumaier, Rainer Hellweg, et al.
Journal of Ect (2020) Vol. 36, Iss. 3, pp. 193-197
Closed Access | Times Cited: 10
The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression
Dore Loef, Kristof Vansteelandt, Mardien L. Oudega, et al.
Brain Behavior & Immunity - Health (2021) Vol. 18, pp. 100389-100389
Open Access | Times Cited: 8
Antidepressant Active Components of Bupleurum chinense DC-Paeonia lactiflora Pall Herb Pair: Pharmacological Mechanisms
Shimeng Lv, Yifan Zhao, Le Wang, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 6
Antidepressant pharmacological mechanisms: focusing on the regulation of autophagy
Shimeng Lv, Guangheng Zhang, Yufei Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
<p>Serum BDNF Levels are Not Associated with the Antidepressant Effects of Nonconvulsive Electrotherapy</p>
Wei Zheng, Miaoling Jiang, Hongbo He, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 1555-1560
Open Access | Times Cited: 5
Early improvement as a predictor of final remission in patients with treatment-resistant depression receiving electroconvulsive therapy with ketofol anesthesia
Wei Zheng, Mei He, Li-Mei Gu, et al.
Journal of Affective Disorders (2022) Vol. 310, pp. 223-227
Closed Access | Times Cited: 3
Adult hippocampal neurogenesis: pharmacological mechanisms of antidepressant active ingredients in traditional Chinese medicine
Shimeng Lv, Guangheng Zhang, Yufei Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Predictors of Response to Electroconvulsive Therapy in Major Depressive Disorder: A Review of Recent Research Findings
Anuradha Baminiwatta, Vikas Menon
Current Behavioral Neuroscience Reports (2024) Vol. 11, Iss. 4, pp. 211-222
Closed Access
Alterations in the Serum Proteome Following Electroconvulsive Therapy for a Major Depressive Episode: A Longitudinal Multicenter Study
Andreas Göteson, Caitlin C. Clements, Anders Juréus, et al.
Biological Psychiatry Global Open Science (2022) Vol. 3, Iss. 4, pp. 884-892
Open Access | Times Cited: 2
Association of Serum BDNF Level and Val66Met Polymorphism with Response to Treatment in Patients of Major Depressive Disease: A Step Towards&nbsp;Personalized Therapy
Sant Ram, Piyush Pathak, Aseem Mehra, et al.
SSRN Electronic Journal (2021)
Closed Access
Page 1 - Next Page

Scroll to top